PROFESSOR COLLET DANDARA
PHD, Fellow Africa Academy of Sciences (AAS), Fellow South African Academy of Sciences (ASSAf)
Professor Collet Dandara is currently serving as Deputy Dean of Postgraduate Education in the Faculty of Health Sciences, at the University of Cape Town. He is also a Director of the SAMRC/UCT Platform for Pharmacogenomics Research and Translation Unit (PREMED) and is a professor of human genomics. Collet Dandara is principal investigator of the pharmacogenomics & drug metabolism research group at the University of Cape Town. Collet is on the Executive Committee of the African Society for Human Genetics (AfSHG) as well as the African Pharmacogenomics Network (APN) and was Chair of the Southern African Society for Human Genetics (SASHG) (2021-2023). Professor Dandara serves on the Board of the Sydney Brenner Institute for Molecular Bioscience and served on the South African Medical Research Council (SAMRC) board from 2019 to 2022. Professor Dandara is a biomedical scientist with extensive experience in pharmacogenomics. Professor Dandara’s research covers the understanding of the pharmacogenomics of antiretroviral drugs and cardiovascular diseases including hypertension and cancer. He is one of the leading experts in pharmacogenomics on the African continent with an international standing in the field. He is a Fellow of the Academy of Science of South Africa (ASSAf Fellow), a Fellow of the African Academy of Science (AAS-Fellow) and was part of the inaugural World Academy of Sciences (TWAS) Young Affiliate/Alumni (TYAN) Executive Committee (2016-2021). He has a track record of successful supervision to graduation of postgraduate students and has supervised to graduation over 30 Honours students, more than 20 MSc students and more than 12 PhD students. He is widely published with >170 publications in international peer-reviewed journals, accumulating Google Scholar H-index of 38 and an i10-index of 110. He has a good understanding of the higher education systems in Africa & internationally, including the funding landscape.
Link to Scopus: https://www.scopus.com/authid/detail.uri?authorId=6603005641
